Related Experiment Video
Updated: Mar 21, 2026

Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
The RNA Binding Protein IMP2 Preserves Glioblastoma Stem Cells by Preventing let-7 Target Gene Silencing
Nils Degrauwe1, Tommy B Schlumpf2, Michalina Janiszewska3
1Division of Experimental Pathology, Institute of Pathology, CHUV, Faculty of Biology and Medicine, University of Lausanne, Rue du Bugnon 25, 1011 Lausanne, Switzerland.
Abstract:
Cancer stem cells (CSCs) can drive tumor growth, and their maintenance may rely on post-transcriptional regulation of gene expression, including that mediated by microRNAs (miRNAs). The let-7 miRNA family has been shown to induce differentiation by silencing stem cell programs. Let-7-mediated target gene suppression is prevented by LIN28A/B, which reduce let-7 biogenesis in normal embryonic and some cancer stem cells and ensure maintenance of stemness. Here, we find that glioblastoma stem cells (GSCs) lack LIN28 and express both let-7 and their target genes, suggesting LIN28-independent protection from let-7 silencing. Using photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP), we show that insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) binds to let-7 miRNA recognition elements (MREs) and prevents let-7 target gene silencing. Our observations define the RNA-binding repertoire of IMP2 and identify a mechanism whereby it supports GSC and neural stem cell specification.
Insights
Glioblastoma stem cells (GSCs) maintain stemness through a LIN28-independent pathway. Insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) prevents let-7 microRNA silencing, supporting GSC and neural stem cell growth.
Area of Science:
- Molecular Biology
- Developmental Biology
- Cancer Research
Background:
- Cancer stem cells (CSCs) drive tumor growth and rely on post-transcriptional gene regulation.
- MicroRNAs (miRNAs), particularly the let-7 family, induce differentiation by silencing stem cell programs.
- LIN28A/B proteins prevent let-7 biogenesis, maintaining stemness in embryonic and some cancer stem cells.
Purpose of the Study:
- To investigate the mechanism of LIN28-independent let-7 silencing protection in glioblastoma stem cells (GSCs).
- To identify factors that maintain stemness in GSCs despite the presence of let-7 and its target genes.
Main Methods:
- Photoactivatable-ribonucleoside-enhanced crosslinking and immunoprecipitation (PAR-CLIP) to identify RNA-binding proteins.
- Analysis of let-7 miRNA and target gene expression in GSCs.
- Investigation of the role of insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) in let-7 regulation.
Main Results:
- Glioblastoma stem cells (GSCs) lack LIN28 but express let-7 and its target genes.
- Insulin-like growth factor 2 mRNA-binding protein 2 (IMP2) binds to let-7 miRNA recognition elements (MREs).
- IMP2 binding prevents let-7-mediated silencing of target genes, thus supporting stemness.
Conclusions:
- Glioblastoma stem cells (GSCs) utilize a LIN28-independent mechanism to maintain stemness.
- IMP2 plays a crucial role in protecting GSCs from let-7-mediated differentiation.
- This mechanism is also relevant for neural stem cell specification.
More Related Videos
09:40Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
10:28Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
Published on: January 10, 2018
Related Concept Videos
MicroRNAs
MicroRNAs
Abnormal Proliferation
Experimental RNAi
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules